Cerebral Perfusion Imaging in Alzheimer's Disease
- 1 February 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 44 (2) , 165-168
- https://doi.org/10.1001/archneur.1987.00520140035014
Abstract
• We used single photon emission computed tomography (SPECT) to study 15 patients with Alzheimer's disease and nine controls. lofetamine hydrochloride I 123 uptake data were recorded from the entire brain using a rotating gamma camera. Activity ratios were measured for the frontal, posterior parietal, posterior, medial, and lateral cortical temporal regions and striate cortex and were normalized by the activity in the cerebellum. Abnormalities in iofetamine hydrochloride I 123 activity were similar to the abnormalities in glucose metabolism observed with positron emission tomography. Cortical tracer activity was globally depressed in patients with Alzheimer's disease, with the greatest reduction in the posterior parietal cortex.This publication has 5 references indexed in Scilit:
- COLLIMATOR SELECTION FOR SPECT BRAIN IMAGING - THE ADVANTAGE OF HIGH-RESOLUTION1986
- Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseAnnals of Neurology, 1985
- A COMPARISON OF 2 CEREBRAL PERFUSION TRACERS, N-ISOPROPYL L-123 PARA-IODOAMPHETAMINE AND I-123 HIPDM, IN THE HUMAN1984
- Alzheimer's diseaseNeurology, 1983
- Cerebral Blood Flow and Oxygen Consumption in ManPhysiological Reviews, 1959